Fluorine in PDB 8gvz: Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil

Enzymatic activity of Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil

All present enzymatic activity of Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil:
3.5.2.3;

Protein crystallography data

The structure of Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil, PDB code: 8gvz was solved by H.W.Liu, P.C.Yang, H.Y.Huang, C.Y.Huang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 28.78 / 1.97
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 81.775, 157.788, 61.828, 90, 90, 90
R / Rfree (%) 17.7 / 21.5

Other elements in 8gvz:

The structure of Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil also contains other interesting chemical elements:

Zinc (Zn) 2 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil (pdb code 8gvz). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil, PDB code: 8gvz:

Fluorine binding site 1 out of 1 in 8gvz

Go back to Fluorine Binding Sites List in 8gvz
Fluorine binding site 1 out of 1 in the Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of the Human Dihydroorotase Domain in Complex with the Anticancer Drug 5-Fluorouracil within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1901

b:20.0
occ:1.00
 F5 A:URF1901 0.0 20.0 1.0
C5 A:URF1901 1.3 20.0 1.0
C6 A:URF1901 2.3 20.0 1.0
C4 A:URF1901 2.4 20.0 1.0
NH2 A:ARG1475 2.5 20.3 1.0
H6 A:URF1901 2.6 20.0 1.0
NE2 A:HIS1690 2.7 22.7 1.0
O4 A:URF1901 2.7 20.0 1.0
CE1 A:HIS1690 2.9 24.1 1.0
CD2 A:PHE1563 3.0 31.0 1.0
CB A:PHE1563 3.1 27.0 1.0
CG A:PHE1563 3.3 29.4 1.0
O A:PRO1702 3.3 21.5 1.0
CZ A:ARG1475 3.4 19.2 1.0
NH1 A:ARG1475 3.4 20.2 1.0
N3 A:URF1901 3.6 20.0 1.0
N1 A:URF1901 3.6 20.0 1.0
CD2 A:HIS1690 4.0 19.3 1.0
CE2 A:PHE1563 4.0 28.8 1.0
CB A:ALA1688 4.1 14.7 1.0
C2 A:URF1901 4.1 20.0 1.0
ND1 A:HIS1690 4.2 22.7 1.0
HN1 A:URF1901 4.3 20.0 1.0
HN3 A:URF1901 4.3 20.0 1.0
CD1 A:PHE1563 4.3 30.9 1.0
CA A:PHE1563 4.5 28.4 1.0
C A:PRO1702 4.5 20.4 1.0
NE A:ARG1475 4.6 19.5 1.0
O A:PHE1563 4.6 33.7 1.0
ND2 A:ASN1505 4.7 21.2 1.0
CG A:HIS1690 4.7 20.0 1.0
CA A:ALA1688 4.8 19.9 1.0
O A:ALA1688 4.8 22.4 1.0
C A:ALA1688 4.9 21.6 1.0
CZ A:PHE1563 4.9 30.5 1.0
CA A:GLY1703 5.0 18.7 1.0

Reference:

E.S.Lin, Y.H.Huang, P.C.Yang, W.F.Peng, C.Y.Huang. Complexed Crystal Structure of the Dihydroorotase Domain of Human Cad Protein with the Anticancer Drug 5-Fluorouracil. Biomolecules V. 13 2023.
ISSN: ESSN 2218-273X
PubMed: 36671534
DOI: 10.3390/BIOM13010149
Page generated: Fri Aug 2 19:58:22 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy